Vera completed a B.Sc. in Bioscience and a M.Sc. in Infection Biology at two Universities in Germany. In 2021 Vera obtained her PhD in medical research at the Kirby Institute, during which she focused on delivery strategies for a potential HIV-1 gene therapy.
Following her PhD, she was recruited to work as a Project Officer to help conduct research on the T cell immune response for multiple clinical research projects, including SARS-CoV-2 infection and vaccination studies.